These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25176157)

  • 1. Recent progress in the development of anti-malarial quinolones.
    Beteck RM; Smit FJ; Haynes RK; N'Da DD
    Malar J; 2014 Aug; 13():339. PubMed ID: 25176157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of potent, novel, non-toxic anti-malarial compounds via quantum modelling, virtual screening and in vitro experimental validation.
    Sullivan DJ; Kaludov N; Martinov MN
    Malar J; 2011 Sep; 10():274. PubMed ID: 21933377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural products as starting points for future anti-malarial therapies: going back to our roots?
    Wells TN
    Malar J; 2011 Mar; 10 Suppl 1(Suppl 1):S3. PubMed ID: 21411014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in the Optimization of 4(1
    Brockmeyer F; Manetsch R
    Chimia (Aarau); 2017 Apr; 71(4):213-219. PubMed ID: 28446339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
    Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
    Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRIMALDDI: platform technologies and novel anti-malarial drug targets.
    Vial H; Taramelli D; Boulton IC; Ward SA; Doerig C; Chibale K
    Malar J; 2013 Nov; 12():396. PubMed ID: 24498961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimalarial drugs and their useful therapeutic lives: rational drug design lessons from pleiotropic action of quinolines and artemisinins.
    Muregi FW
    Curr Drug Discov Technol; 2010 Dec; 7(4):280-316. PubMed ID: 21034413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the automated haematology analyzer XN-30 for discovery and development of anti-malarial drugs.
    Tougan T; Toya Y; Uchihashi K; Horii T
    Malar J; 2019 Jan; 18(1):8. PubMed ID: 30642330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the active sites of malarial proteases for antimalarial drug discovery: approaches, progress and challenges.
    Roy KK
    Int J Antimicrob Agents; 2017 Sep; 50(3):287-302. PubMed ID: 28668681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum.
    Duffey M; Sanchez CP; Lanzer M
    Malar J; 2018 Mar; 17(1):121. PubMed ID: 29558913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New developments in anti-malarial target candidate and product profiles.
    Burrows JN; Duparc S; Gutteridge WE; Hooft van Huijsduijnen R; Kaszubska W; Macintyre F; Mazzuri S; Möhrle JJ; Wells TNC
    Malar J; 2017 Jan; 16(1):26. PubMed ID: 28086874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya.
    Spalding MD; Eyase FL; Akala HM; Bedno SA; Prigge ST; Coldren RL; Moss WJ; Waters NC
    Malar J; 2010 Nov; 9():338. PubMed ID: 21106088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantiomerically pure amino-alcohol quinolines: in vitro anti-malarial activity in combination with dihydroartemisinin, cytotoxicity and in vivo efficacy in a Plasmodium berghei mouse model.
    Mullié C; Taudon N; Degrouas C; Jonet A; Pascual A; Agnamey P; Sonnet P
    Malar J; 2014 Oct; 13():407. PubMed ID: 25319003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying rapidly parasiticidal anti-malarial drugs using a simple and reliable in vitro parasite viability fast assay.
    Linares M; Viera S; Crespo B; Franco V; Gómez-Lorenzo MG; Jiménez-Díaz MB; Angulo-Barturen Í; Sanz LM; Gamo FJ
    Malar J; 2015 Nov; 14():441. PubMed ID: 26542470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro anti-malarial interaction and gametocytocidal activity of cryptolepine.
    Forkuo AD; Ansah C; Mensah KB; Annan K; Gyan B; Theron A; Mancama D; Wright CW
    Malar J; 2017 Dec; 16(1):496. PubMed ID: 29282057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development.
    Zaloumis S; Humberstone A; Charman SA; Price RN; Moehrle J; Gamo-Benito J; McCaw J; Jamsen KM; Smith K; Simpson JA
    Malar J; 2012 Aug; 11():303. PubMed ID: 22931058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-(1H)-Quinolones and 1,2,3,4-Tetrahydroacridin-9(10H)-ones prevent the transmission of Plasmodium falciparum to Anopheles freeborni.
    Sáenz FE; Lacrue AN; Cross RM; Maignan JR; Udenze KO; Manetsch R; Kyle DE
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6187-95. PubMed ID: 24080648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent in vivo anti-malarial activity and representative snapshot pharmacokinetic evaluation of artemisinin-quinoline hybrids.
    Lombard MC; N'Da DD; Tran Van Ba C; Wein S; Norman J; Wiesner L; Vial H
    Malar J; 2013 Feb; 12():71. PubMed ID: 23433124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-malarial effect of semi-synthetic drug amitozyn.
    Tcherniuk SO; Chesnokova O; Oleinikov IV; Potopalsky AI; Oleinikov AV
    Malar J; 2015 Oct; 14():425. PubMed ID: 26515752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The past, present and future of anti-malarial medicines.
    Tse EG; Korsik M; Todd MH
    Malar J; 2019 Mar; 18(1):93. PubMed ID: 30902052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.